Comparison

Endostatin, Human European Partner

Manufacturer GenScript
Category
Type Proteins
Specific against Human
Amount 20ug
Item no. Z02533-20
Targets VEGFA, FOXD3, FGF2
eClass 6.1 34160400
eClass 9.0 42020190
Available
Specificity
Determined by Endothelial Cell Tube Formation. The cells treated with 10μ, g/ml Endostatin showed significant anti-angiogenesis effect.
Description
Endostatin is a cleaved product of the carboxyl-terminal domain of collagen XVIII. It functions as an anti-angiogenic cytokine that is expressed in various organs especially with high levels in liver, lung, and kidney. Endostatin inhibits angiogenesis by blocking the pro-angiogenic activities of VEGF and FGF-basic. Recombinant Endostatin expressed in yeast, whichcauses G1 arrest of endothelial cells. Endostatin treatment results in apoptosis of HUVE and HMVE cells. Recombinant human Endostatin is a 20.2 kDa protein consisting of 184 amino acid residues.
Endotoxin Level
Endotoxin level is less than 0.1 ng per ug (1EU/ug) of Endostatin.
Formulation
The sterile filtered solution was lyophilized with 17 mM citric-phosphate buffer, pH 6.2.
Product Line
Others
Storage
The lyophilized Endostatin is stable for a few weeks at room temperature, but best stored at -20C. For the first use, reconstitute in water, aliquot and store at -20C to avoid multiple freeze-thaws.
Product Origin
USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 20ug
Available: In stock
available

Delivery expected until 5/9/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close